Skip to main content
A randomized phase III trial of BIBW 2992 versus chemotherapy as first-line treatment for stage IIIB/IV adenocarcinoma of the lung harboring an epidermal growth factor receptor-activating mutation
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
A randomized phase III trial of BIBW 2992 versus chemotherapy as first-line treatment for stage IIIB/IV adenocarcinoma of the lung harboring an epidermal growth factor receptor-activating mutation
User login
Username
Password
Reset your password
Type
Lead
score